Virbac: FY sales pretty flat

(CercleFinance.com) - Virbac, a company specialied in animal health, has posted full-year revenue of 934.
2 million euros, up 1.8% excluding Sentinel (-0.4% at actual exchange rates and consolidation scope).

Excluding unfavourable FX factors, revenues increased by 5.7% excluding Sentinel.

The animal health group confirms that the ratio of underlying operating profit before the amortisation of assets from acquisitions to sales should be around 14% at constant exchange rates and at an actual consolidation scope in 2020.

In 2021, it expects LFL sales growth of 3% to 5% (0% and 2% at constant exchange rates and actual consolidation scope), as well as underlying OP before the amortisation of assets acquired to sales ratio of between 10% and 12% at constant exchange rates.


Copyright (c) 2021 CercleFinance.com. All rights reserved.